AIA
SNY icon

Angeles Investment Advisors’s Sanofi SNY Stock Holding History

Angeles Investment Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,989
Closed -$530K – 167
2024
Q4 		$530K Sell
10,989
-334
-3% -$17K 0.03% 85
2024
Q3 		$653K Buy
11,323
+210
+2% +$11.3K 0.03% 75
2024
Q2 		$539K Sell
11,113
-978
-8% -$47.2K 0.03% 95
2024
Q1 		$588K Buy
12,091
+62
+0.5% +$3.03K 0.03% 88
2023
Q4 		$598K Buy
12,029
+244
+2% +$11.9K 0.04% 78
2023
Q3 		$632K Sell
11,785
-726
-6% -$38.7K 0.05% 57
2023
Q2 		$674K Buy
12,511
+66
+0.5% +$3.55K 0.06% 46
2023
Q1 		$677K Buy
12,445
+3,744
+43% +$182K 0.06% 39
2022
Q4 		$421K Buy
+8,701
New +$382K 0.04% 44
2022
Q3 		– Sell
-4,715
Closed -$236K – 107
2022
Q2 		$236K Buy
+4,715
New +$250K 0.02% 94

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Angeles Investment Advisors's SNY Position: Q1 2025 in Review

Angeles Investment Advisors sold out of Sanofi (SNY) in Q1 2025, closing a stake of 10,989 shares — an estimated $530K sold.

Angeles Investment Advisors first reported a position in SNY in Q2 2022 and held it in 10 quarters. The position peaked at $677K in Q1 2023. 772 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Angeles Investment Advisors reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
  • Angeles Investment Advisors sold 10,989 Sanofi shares in Q1 2025, an estimated $530K.
  • Angeles Investment Advisors first reported a position in Sanofi in Q2 2022 and held it in 10 quarters.
  • Angeles Investment Advisors's Sanofi position peaked at $677K in Q1 2023.
  • 772 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.